Alexandre Becker/LinkedIn
May 15, 2026, 15:46
Alexandre Becker: Clinical Importance of Neonatal Thrombocytopenia in Newborns
Alexandre Becker, Professor of Postgraduate Studies in Clinical Hematology, Hemotherapy, and Quality Management and Control at ULBRA, shared a post on LinkedIn:
”Neonatal Thrombocytopenia
Neonatal thrombocytopenia is a common condition in neonatal intensive care units (15–40percent of infants), serving as a crucial marker of severe diseases such as sepsis, viral infection, necrotizing enterocolitis, or alloimmunization.
Its importance lies in the high risk of bleeding (including intracranial hemorrhage) and the need for rapid diagnosis to differentiate treatable causes and prevent serious sequelae or death.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization